Position Statements for the Implementation of Oncology Biosimilars from the pan-Canadian Clinical Operations Working Group
The objective of the Position Statement is to provide recommendations to assist hospitals and cancer centers appropriately prepare for the implementation of oncology biosimilars.
Intended Guideline Users
Prescribers, pharmacists, nurses, health administrators
Prescribers, pharmacists, nurses, and health administrators are invited to submit feedback on these recommendations through their Clinical Operations Working Group representative, or by sending an email to the pan-Canadian Oncology Biosimilars Initiative.